Type of Study:

Interventional

Study Design:

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor)

Outcome Measure:

arterial oxygenation

Outcome Description:

T1,T2,T3,T4: all measurement in lateral position, T1-arterial oxygenation(PaO2), T2-arterial oxygenation(PaO2),T3-arterial oxygenation(PaO2),T4-arterial oxygenation(PaO2)

Outcome Time Frame:

T1(10min before one-lung ventilation),T2(30min after one-lung ventilation),T3(60min), T4(10min after two lung ventilation)

Safety Issue:

Yes

Principal Investigator

Young Jun Oh, M.D.,PhD.

Investigator Role:

Study Chair

Investigator Affiliation:

Yonsei University College of Medicine

Authority:

Korea: Food and Drug Administration

Study ID:

1-2011-0027

NCT ID:

NCT01636973

Start Date:

March 2011

Completion Date:

April 2012

Related Keywords:

• Lung Cancer
• Lung cancer
• Lung Neoplasms